Previously, we have shown that VEGF expression in ovarian cancer induces MDSCs and promotes tumour progression through immunosuppression.9 Contrary to expectations, in anti-VEGF antibody-treated HM-1 tumour, MDSC numbers were increased, whereas CD8 + lymphocyte numbers were decreased (Fig. 1c–e). Here, VEGFA is linked to ovarian cancer.